REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/09/2025
Back to search
Official data from USPTO
INVENTAGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INVENTAGE
ST13
US500000079266586Class
5, 10
Filing
79266586
Registration
6071903
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
06/10/2025
Trademark type
Word
Nice classes
5, 10
Filing date
07/05/2019
Registration date
06/09/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/09/2020
Last transaction
06/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Seongnam-si, G, KR
Examiner
KLEINMAN, CORINNE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Inventage Lab Inc.
Representatives
Paul G. Johnson Maschoff Brennan
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal infusions for treating dementiadiabetesobesityandropathyalopeciaincurable diseasechronic diseaselipolysisboosting the immune system; Medicinal infusions for treating dirofilaria immitis diseasesinfectious diseasesskeletal and muscular disorderscardiovascular and circulatory diseasesnervous system diseasesocular disordersrespiratory diseasesgastrointestinal diseasesendocrine diseaseskidney diseaseshormonal diseasesoncological diseases and disorders of animals; implantable medicines in the nature of surgical implants comprised of living tissues; pharmaceutical compositions for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti-infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; pharmaceutical compositions for animal skincare; pharmaceutical compositions for skin care; pharmaceutical compositions for treating dirofilaria immitis diseasesinfectious diseasesskeletal and muscular disorderscardiovascular and circulatory diseasesnervous system diseasesocular disordersrespiratory diseasesgastrointestinal diseasesendocrine diseaseskidney diseaseshormonal diseasesoncological diseases and disorders of animals; medicines for human purposesmedicines for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; drugs in the nature of pharmaceutical preparations for medical purposesfor the treatment of oncologicalgastrointestinalmetabolicchronicendocrinerespiratoryneurological and ophthalmic diseases and disorders; therapeutic drugs and agents in the nature of therapeutic pharmaceutical and agents for the treatment of oncologicalgastrointestinalmetabolicchronicendocrinerespiratoryneurological and ophthalmic diseases and disorders; therapeutic drugs and agents in the nature of therapeutic pharmaceutical and agents for treating dirofilaria immitis diseasesinfectious diseasesskeletal and muscular disorderscardiovascular and circulatory diseasesnervous system diseasesocular disordersrespiratory diseasesgastrointestinal diseasesendocrine diseaseskidney diseaseshormonal diseasesoncological diseases and disorders of animals; chemical preparations for pharmaceutical purposesfor the treatment of oncologicalgastrointestinalmetabolicchronicendocrinerespiratoryneurological and ophthalmic diseases and disorders
Class 10
Medical apparatus and instruments for use in endovascularcardiovascularendoscopy procedures; medical instruments for use in drug delivery systems; medical instruments for use in monitoring oxymetorygas analysisvital signsblood properties and respiratory events; medical instruments for use in treating osteoarthritisosteoporosisosteotraumatic injuriesdegenerative bone diseases and joint diseases; medical instruments to measure blood pressurecardiac output and other physiological and cardiovascular parameters; medical instruments for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; medical filler apparatus in the nature of synthetic filler and extender material to serve as replacement for bone; medical apparatus and instrumentsinfusion and injection devices for administering pharmaceuticals; diagnostic apparatus and instruments for medical purposesmedical diagnostic apparatus for testing blood sugar levelscancer cellsDNAurinary proteincholesterol level; injection device for pharmaceuticals; medical apparatusinfusion and injection devices for administering pharmaceuticals
Publications
History of USPTO decisions and trademark events.
23 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/28/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/25/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/02/2020
FIMP
FINAL DISPOSITION PROCESSED
10/02/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/24/2020
PUBO
PUBLISHED FOR OPPOSITION
03/24/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/23/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/23/2020
RFNT
REFUSAL PROCESSED BY IB
10/19/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/01/2019
RFRR
REFUSAL PROCESSED BY MPU
10/01/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/25/2019
CNRT
NON-FINAL ACTION WRITTEN
09/24/2019
DOCK
ASSIGNED TO EXAMINER
09/23/2019
MAFR
APPLICATION FILING RECEIPT MAILED
09/17/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/05/2019
Continuous trademark protection
Get notified about every new filing that threatens INVENTAGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.